Alembic Pharmaceuticals Ltd
Urvish Modh has a diverse work experience in the pharmaceutical industry. Urvish started their career in 2009 as a Research Associate in Zydus Cadila, where they worked on analytical method development and sample analysis for injectable and solid oral dosage forms. Urvish then moved to Sun Pharma Advanced Research Company Ltd. in 2010 and held roles as a Research Assistant and Research Officer, specializing in NDDS formulation and method development. In 2016, Urvish joined Emcure Pharmaceuticals Limited, starting as an Assistant Manager and eventually progressing to Manager and Sr. Manager roles. Urvish'sresponsibilities at Emcure included managing teams and overseeing various projects. Currently, they are a Principal Scientist at Alembic Pharmaceuticals Limited, where they are expected to start in 2023. The specific details of their role at Alembic are not provided.
Urvish Modh obtained their M.Pharm degree in Quality Assurance from Shri Sarvajanik Pharmacy College, Mehsana, from 2007-2009. Prior to that, they completed their B.Pharm degree in Pharmaceutical Sciences from B.M.Shah College of Pharmaceutical Education and Research, Modasa, from 2003-2007.
This person is not in the org chart
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.